CD8A and neoplasm: As there was no evidence of cytokine modulation in intratumoral E7-specific CD8+T cells that explained the superior therapeutic efficacy of E7 RNA-LPX/LRT over E7 RNA-LPX monotherapy, we investigated the impact of treatment on tumor cells, which are the vital cellular subset directly targeted by antigen-specific T cells.